Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 272, Issue 2 16-2, 1997, Pages

  Murakami, Kazunori ^a   Okajima, Kenji ^a   Uchiba, Mitsuhiro ^a   Johno, Masayoshi ^a   Nakagaki, Tomohiro ^b   Okabe, Hiroaki ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

activated leukocytes; endotoxin

Indexed keywords

ACTIVATED PROTEIN C; CYTOKINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; ENZYME ANALYSIS; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0030909690     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.272.2.l197     Document Type: Article

References (34)

1. Bajaj, S. P., S. I. Rapaport, and C. A. Prodanos. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep. Biochem. 11: 397-412, 1981.
2. Berkow, R. L., D. Wang, J. W. Larrick, R. W. Dodson, and T. H. Howard. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J. Immunol. 139: 3783-3791, 1987.
3. Casey, L. C., R. A. Balk, and R. C. Bone. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119: 771-778, 1993.
4. Chang, S. W., N. Ohara, G. Kuo, and N. F. Voelkel. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L232-L239, 1989.
5. Ernst, E., D. E. Hammerschmidt, U. Bagge, A. Matrai, and J. A. Dormandy. Leukocytes and the risk of ischemic diseases. J. Am. Med. Assoc. 257: 2318-2324, 1987.
6. Esmon, C. T. The protein C anticoagulant pathway. Arterioscler. Thromb. 12: 135-145, 1992.
7. Esmon, C. T., F. B. Taylor, Jr., and T. R. Snow. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb. Haemostasis 66: 160-165, 1991.
8. Ford, T. C., and D. Rickwood. Formation of isotonic Nycodenz gradients for cell separations. Anal. Biochem. 124: 293-298, 1982.
9. Grey, S., H. Hau, H. H. Salem, and W. W. Hancock. Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-γ, or PMA: modulation of effects on CD11b and CD14 but not CD25 or CD54 induction. Transplant. Proc. 25: 2913-2914, 1993.
10. Grey, S. T., A. Tsuchida, H. Hau, C. L. Orthner, H. H. Salem, and W. W. Hancock. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ, or phorbol ester. J. Immunol. 153: 3664-3672, 1994.
11. Grinnell, B. W., R. B. Hermann, and S. B. Yan. Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 4: 221-225, 1994.
12. Kushimoto, S., K. Okajima, H. Okabe, and B. R. Binder. Role of granulocyte elastase in the formation of hemorrhagic shock-induced gastric mucosal lesions in the rat. Crit. Care Med. 24: 1041-1046, 1996.
13. Kushimoto, S., K. Okajima, M. Uchiba, K. Murakami, N. Harada, H. Okabe, and K. Takatsuki. Role of granulocyte elastase in ischemia/reperfusion injury of rat liver. Crit. Care Med. In press.
14. Léculier, C., N. Couprie, P. Adeleine, P. Leitienne, A. Francina, and M. Richard. The effect of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes. Thromb. Res. 69: 519-531, 1993.
15. Morita, T., and C. M. Jackson. Localization of the structural difference between bovine blood coagulation factor X1 and X2 to tyrosine 18 in the activation peptide. J. Biol. Chem. 261: 4008-4014, 1986.
16. Mulligan, M. S., M. J. Polley, R. J. Bayer, M. F. Nunn, J. C. Paulson, and P. A. Ward. Neutrophil-dependent acute lung injury. Requirment for P-selectin (GMP-140). J. Clin. Invest. 90: 1600-1607, 1992.
17. Murakami, K., K. Okajima, M. Uchiba, M. Johno, T. Nakagaki, H. Okabe, and K. Takatsuki. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87: 642-647, 1996.
18. Okajima, K., S. Koga, M. Kaji, M. Inoue, T. Nakagaki, A. Funatsu, H. Okabe, K. Takatsuki, and N. Aoki. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects. Thromb. Haemostasis 63: 48-53, 1990.
19. Parrillo, J. E. Pathogenic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477, 1993.
20. Pober, J. S., and R. S. Cotran. The role of endothelial cells in inflammation. Transplantation 50: 537-544, 1990.
21. Russel-Smith, N. C., R. J. Flower, and D. C. Cardinal. Measuring platelet and leukocyte aggregation/adhesion responses in very small volumes of whole blood. J. Pharmacol. Methods 6: 315-333, 1981.
22. Snow, T. R., M. T. Deal, D. T. Dickey, and C. T. Esmon. Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation 84: 293-299, 1991.
23. St. John, R. C., and P. M. Dorinsky. Immunologic therapy for ARDS, septic shock and multiple organ failure. Chest 103: 932-943, 1993.
24. 2) and hydroxyl radical production by human polymorphonuclear leukocytes. Hepatogastroenterology 39: 59-61, 1992.
25. Tanaka, H., T. Shimazu, H. Sugimoto, T. Yoshioka, and T. Sugimoto. A sensitive and specific assay for granulocyte elastase in inflammatory tissue fluid using L-pyroglutamyl-L-prolyl-L-valine-p-nitroanilide. Clin. Chim. Acta 187: 173-180, 1990.
26. Taylor, F. B., A. Chang, C. T. Esmon, A. D'Angelo, S. Vigano-D'Angelo, and K. E. Blick. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J. Clin. Invest. 79: 918-925, 1987.
27. Taylor, F. B., A. C. K. Chang, G. T. Peer, T. Mathe, K. Blick, R. Catlett, C. M. S. Lockhart, and C. T. Esmon. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 78: 364-368, 1991.
28. Tedder, T. F., D. A. Steeber, A. Chen, and P Engel. The selectins: vascular adhesion molecules. FASEB J. 9: 866-873, 1995.
29. Walker, F. J., P. W. Sexton, and C. T. Esmon. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim. Biophys. Acta 571: 333-342, 1979.
30. Ward, P.A., M. S. Mulligan, and A. A. Vaporciyan. Endothelial and leukocytic adhesion molecules in the pathogenesis of acute pulmonary injury. Thromb. Haemostasis 70: 155-157, 1993.
31. Watabe, S., F. Sendo, S. Kimura, and S. Arai. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432. J. Natl. Cancer Inst. 72: 1365-1370, 1984.
32. Wedmore, C. V., and T. J. Williams. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature Lond. 289: 646-650, 1981.
33. Zhang, X., and E. F. Ellis. Superoxide dismutase reduces permeability and edema induced by hypertension in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H497-H503, 1990.
34. Zimmerman, B. J., and D. N. Granger. Reperfusion-induced leukocyte infiltration: role of elastase. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H390-H394, 1990.